Eastman Chemical (EMN) Leaves Defensive Indexes, Is The Stock Still Below Fair Value?
Eastman Chemical (EMN) was recently removed from Russell 1000 Defensive indexes, leading to potential rebalancing by index-tracking funds. Despite recent short-term price drops, Simply Wall St's analysis suggests EMN is 18.3% undervalued with a fair value of $84.33, primarily due to its specialty materials and recycling roadmap. However, the company faces risks from weaker demand in automotive and construction sectors and slower adoption of recycled products.
Eastman Chemical (EMN) Leaves Defensive Indexes, Is The Stock Still Below Fair Value?
Eastman Chemical (EMN) was recently removed from the Russell 1000 Defensive and Russell 1000 Value Defensive indexes, potentially leading to rebalancing by index-tracking funds. Despite recent short-term negative momentum in its stock price, Simply Wall St's analysis suggests Eastman Chemical is undervalued with a fair value of $84.33, compared to its current share price of $68.9. The valuation is driven by the company's specialty materials and recycling initiatives, though risks such as weaker demand in automotive and construction sectors remain.
Can DOW's Strong Liquidity Drive Future Growth and Returns?
Dow Inc. (DOW) demonstrated strong liquidity in the first quarter with $14 billion in total liquidity and $1.1 billion in operating cash flow, positioning it to finance growth in high-value businesses and return capital to shareholders. Compared to competitors like LyondellBasell and Eastman Chemical, Dow's financial health allows for strategic investments and consistent dividends. Despite a recent stock decline, DOW holds a Zacks Rank #3 (Hold) with a favorable valuation and positive earnings estimate trends for 2026.
ASPI - ASP Isotopes Inc Volatility & Greeks
This article provides a detailed financial overview of ASP Isotopes Inc (ASPI), including its last closing price, financial ratios, earnings per share, sales performance, insider/institutional ownership, and various volatility metrics. The data reflects a recent closing price of $5.53, a significant year-over-year sales growth, and high volatility.
How Investors May Respond To Eastman Chemical (EMN) Losing Its Russell Defensive Index Placements
Eastman Chemical (EMN) was recently removed from the Russell 1000 Defensive and Russell 1000 Value-Defensive Indexes, potentially leading to portfolio rebalancing and shifts in investor perception. While this removal doesn't alter the core fundamental story of molecular recycling progress, it highlights the ongoing challenges of near-term earnings pressure and cyclical demand risk. Investors are encouraged to consider diverse perspectives, including analysts' more pessimistic views on margin pressure, against the company's projected revenue and earnings growth.
How Investors May Respond To Eastman Chemical (EMN) Losing Its Russell Defensive Index Placements
Eastman Chemical (EMN) was recently removed from the Russell 1000 Defensive Index and Russell 1000 Value-Defensive Index. This change could lead to portfolio rebalancing by benchmark-tracking funds and alter institutional investor perception. The article discusses how this removal affects Eastman's investment narrative, particularly its core focus on specialty materials and recycling amidst recent earnings softness and cyclical demand risks.
Dow Inc. outlines its role in global materials markets
Dow Inc. is a major global materials science company that supplies plastics, chemicals, and packaging materials across diverse industries. The company focuses on efficiency, innovation, and sustainability, balancing short-term market conditions with long-term capital allocation strategies. Dow Inc. aims to meet evolving customer needs through a portfolio optimized for scale, cost efficiency, and technical differentiation, with an increasing focus on sustainability and global economic trends.
WLK - Westlake Corp Forecast, Target Price
This article provides a detailed financial overview and forecast for Westlake Corp (WLK). It includes key financial metrics, stock performance data, analyst recommendations, and insider/institutional ownership percentages. The company's last close was $74.77, with a target price of $106.06.
NGVT - Ingevity Corp Latest SEC Filings
This article provides the latest SEC filings and comprehensive financial overview for Ingevity Corp (NGVT). It includes key financial metrics, performance indicators, insider ownership details, and market data, offering a snapshot of the company's current financial health and market standing.
CC - Chemours Company Latest SEC Filings
This article provides a detailed financial overview of The Chemours Company (CC), including its latest stock performance, key financial metrics, valuation ratios, and insider/institutional ownership. It highlights a recent price drop of 5.61%, with the stock closing at $19.01, and includes various performance indicators over different timeframes, analyst recommendations, and an earnings surprise for the last quarter.
MTX - Minerals Technologies Inc Volatility & Greeks
This article provides a detailed financial snapshot of Minerals Technologies Inc (MTX), covering its last close price, market capitalization, income, sales, various financial ratios, and performance metrics. It also includes key data points such as dividend information, insider and institutional ownership, analyst recommendations, and volatility measures.
GEVO - Gevo Inc Volatility & Greeks
This page provides a comprehensive overview of GEVO (Gevo Inc) stock, detailing its current market performance, key financial metrics, and options-related data. It includes information on volatility, share statistics, analyst recommendations, and various performance indicators over different periods. The data covers current price, changes, market capitalization, income, sales, and insider/institutional ownership.
KOP - Koppers Holdings Inc Options
This article provides a detailed financial overview of Koppers Holdings Inc. (KOP), including its stock performance metrics, valuation ratios, income statement data, balance sheet figures, and insider/institutional ownership. It covers key financial statistics such as market cap, P/E, EPS, sales, and dividend information, offering a comprehensive snapshot for potential investors.
ESI - Element Solutions Inc Latest SEC Filings
This article provides the latest SEC filings information for Element Solutions Inc (ESI), a specialty chemicals company. It details the company's financial overview, including market cap, income, sales, dividends, and key financial ratios. The report also lists performance metrics, insider and institutional ownership, and analyst recommendations.
FUL - H.B. Fuller Company Options
This article provides a detailed financial overview of H.B. Fuller Company (FUL). It includes key financial metrics such as market capitalization, income, sales, dividend information, and various price ratios. The report also covers insider and institutional ownership, profitability, stock performance, and analyst recommendations.
Eastman Chemical Co. stock outperforms competitors on strong trading day
Eastman Chemical Co. (EMN) saw its stock advance by 2.64% to $68.86 on Thursday, outperforming competitors in a mixed trading session. The S&P 500 Index remained mostly unchanged, while the Dow Jones Industrial Average rose by 1.14%. This marks the third consecutive day of gains for Eastman Chemical Co.
Should Value Investors Buy Eastman Chemical (EMN) Stock?
Eastman Chemical (EMN) appears to be an attractive option for value investors, currently holding a Zacks Rank #2 (Buy) and a Value Grade of A. The stock's Forward P/E ratio of 9.55 is favorable compared to its industry average of 12.70, and its P/B ratio of 1.27 is also below the industry average of 2.06. These metrics suggest that EMN may currently be undervalued by the market.
DOW's Shares Rise 16% YTD: How Should You Play the Stock?
Dow Inc. (DOW) shares have risen 15.5% year-to-date, outperforming the S&P 500 and matching its industry, driven by cost reduction and strategic growth efforts. Despite soft demand and cost pressures, the company's strong financial health and positive analyst sentiment suggest a hold strategy for existing investors. Dow is focusing on high-return growth projects, cost-cutting initiatives, and maintaining a strong balance sheet to navigate market challenges.
ASH - Ashland Inc Volatility & Greeks
The article provides a detailed financial overview of Ashland Inc. (ASH), including its stock performance, volatility, key financial ratios, earnings per share (EPS) trends, and ownership data. It highlights the company's current stock price, market capitalization, dividend information, and various performance metrics over different periods.
DD - DuPont de Nemours Inc Options
This article provides detailed financial data and stock performance metrics for DuPont de Nemours Inc. (DD). It covers key financial figures like market cap, income, sales, P/E ratio, dividend information, and various performance indicators over different periods. The data indicates DD's recent stock movements and its standing within the specialty chemicals sector.
Olin, Huntsman in merger
Olin Corp. and Huntsman Corp. announced an all-stock merger agreement to combine their businesses, creating a North American chemical manufacturing giant with an enterprise value exceeding $12 billion. The merger is expected to generate approximately $500 million in annual cost synergies within three years. Olin shareholders will own 60% and Huntsman shareholders 40% of the combined company.
RBC Cuts Price Target on Eastman Chemical to $69 From $82, Keeps Sector Perform Rating
RBC has lowered its price target for Eastman Chemical (NYSE:EMN) to $69 from $82, while maintaining a "Sector Perform" rating on the stock. This adjustment comes after Eastman Chemical's recent announcement of its Q1 2026 adjusted earnings and revenue decline, along with a Q2 outlook. The company also recently acquired Brand and certain assets related to Arkema France SA's Jaryle dielectric fluids business.
Stepan (SCL) Joins Russell 2000 Dynamic Index Is Its Small-Cap Profile Quietly Shifting?
Stepan Company (SCL) has been added to the Russell 2000 Dynamic Index, which is expected to increase its visibility and liquidity among institutional investors. While this inclusion is significant, the company's immediate focus remains on improving profitability, managing raw material and pricing pressures, and scaling new capacity. Forecasts suggest Stepan could reach $2.8 billion in revenue and $137.8 million in earnings by 2029, with a fair value indicating a 35% upside.
Eastman Chemical Co (EMN) Shares Fall 5.4% -- What GF Score of 74 Tells Investors
Eastman Chemical Co (EMN) shares dropped 5.4% to $66.92, yet GuruFocus assesses the stock as "Modestly Undervalued" with a GF Value™ of $78.59, offering a 14.8% potential upside. Despite a strong GF Score™ of 74/100, insider selling and a low growth score of 3/10 raise caution for investors. The company's current P/E of 19.4x is also above its 5-year median, suggesting a premium compared to historical valuation.
ESI - Element Solutions Inc Volatility & Greeks
This article provides a detailed financial overview of Element Solutions Inc (ESI), including its latest stock performance, market capitalization, key financial ratios, and volatility metrics. It covers various aspects like insider and institutional ownership, analyst recommendations, and historical performance, presenting a comprehensive snapshot of the company's financial health.
CC - Chemours Company Options
This page provides a detailed financial overview of The Chemours Company (CC), including its latest stock performance, key financial metrics, various ratios, and analyst recommendations. It highlights the company's market capitalization, income, sales, dividend information, and ownership details, alongside performance metrics over different timeframes.
Eastman Chemical Co (EMN) Shares Fall 5.4% -- What GF Score of 74 Tells Investors
Eastman Chemical Co (EMN) shares dropped 5.4% to $66.92, trading below its intrinsic value as indicated by a "Modestly Undervalued" GF Value™ of $78.59. Despite a strong GF Score™ of 74/100, driven by a perfect 10/10 in Valuation, the company faces challenges with a low Growth score (3/10) and insider selling activity totaling $0.1 million over the last three months. Investors are cautioned to weigh the potential undervaluation against the risks of low growth and insider sentiment.
Seagate Technology Holdings Jumps 7.0% After Cantor Fitzgerald Maintains Overweight
Seagate Technology Holdings plc (STX) saw its stock jump 7.0% after Cantor Fitzgerald upgraded its rating to Overweight and significantly raised its price target from $1000 to $1300. This upgrade, partly driven by new product contracts, indicates strong confidence in Seagate's potential for growth within the storage technology sector. The substantial price target increase and heightened trading volume highlight the market's positive response to this bullish analyst endorsement.
Eastman Chemical Company(NYSE: EMN) dropped from Russell 1000 Defensive Index
Eastman Chemical Company (NYSE: EMN) has been removed from the Russell 1000 Defensive Index. This news follows several recent updates for the company, including an acquisition, conference presentation, and dividend announcement, as well as its Q1 2026 earnings report and analyst rating adjustments.
Eastman Chemical Co. stock underperforms Monday when compared to competitors
Eastman Chemical Co. (EMN) shares dropped 5.36% on Monday, closing at $66.92, despite a positive trading session for the broader market. This decline ended a three-day winning streak for the company's stock. The S&P 500 Index and the Dow Jones Industrial Average both saw gains on the same day.
Eastman Chemical Drops 5.7% Amid Sector-Wide Selling
Eastman Chemical Company experienced a 5.7% drop in its stock price, closing at $66.65 on Monday, amidst a broad market selloff affecting the specialty chemicals sector. This decline was mirrored by other companies in the sector, suggesting a broader investor rotation away from specialty chemicals due to potential concerns about demand, input costs, or macroeconomic factors, rather than company-specific issues. Heightened trading volume and a lack of recent analyst upgrades further indicate a reassessment of the sector's near-term prospects.
H.C. Wainwright upgrades Prime Medicine stock rating to buy
H.C. Wainwright has upgraded Prime Medicine (NASDAQ:PRME) from Neutral to Buy, setting an $8.00 price target after New Zealand approved the Clinical Trial Application for PM577a, an investigational therapy for Wilson’s Disease. This clearance marks the first clinical authorization for an in vivo Prime Editing therapy from the company, enabling a global Phase 1/2 study to commence in the second half of 2026. Despite the stock being potentially overvalued according to InvestingPro data, and the company burning cash quickly, its strong current ratio offers liquidity, with H.C. Wainwright viewing the clinical clearance as a significant de-risking event.
How Investors May Respond To Eastman Chemical (EMN) Losing Russell 1000 Defensive Index Inclusion
Eastman Chemical (EMN) has been removed from the Russell 1000 Value-Defensive and Defensive Indexes, impacting how some passive funds may hold the stock. The company's investment narrative focuses on its shift to specialty materials and molecular recycling, with its Kingsport methanolysis facility expected to contribute significantly to earnings. Investors should monitor the progress of its recycling growth, alongside its elevated net debt and dividend coverage.
How Investors May Respond To Eastman Chemical (EMN) Losing Russell 1000 Defensive Index Inclusion
Eastman Chemical (EMN) was removed from the Russell 1000 Value-Defensive and Defensive Indexes, which could impact how passive funds invest in the stock. This move occurs as Eastman focuses on molecular recycling and maintaining its dividend record, aiming for higher-value specialty materials despite challenges like cyclical demand and debt. While some analysts are optimistic about its Kingsport facility's potential, investors should also consider risks like its elevated net debt and dividend coverage.
HB Fuller moves to acquire advanced medical solutions in strategic deal
H.B. Fuller, the world’s largest pure-play adhesives manufacturer, announced its intent to acquire Advanced Medical Solutions Group in an all-cash offer valued at £715 million. This strategic acquisition aims to significantly expand H.B. Fuller's presence in high-growth medical markets, including medical adhesives and biosurgical technologies, projecting an increase of $15 billion to its total addressable market. The deal, expected to close by year-end 2026, also anticipates £55 million in annual run-rate synergies by 2031 through cost savings and operational efficiencies.
Enterprise value to EBIT forward of Eastman Chemical Company – BMV:EMN
This article provides financial data for Eastman Chemical Company (BMV:EMN) on TradingView, specifically focusing on its enterprise value to EBIT forward. It indicates what information is available on the platform and highlights the financial metrics for the company.
Enterprise value to revenue forward of Eastman Chemical Company – BMV:EMN
This article displays the "Enterprise value to revenue forward" metric for Eastman Chemical Company (BMV:EMN) on TradingView. It indicates that the market is closed and no trades have occurred for this specific metric. The content highlights financial data provided by ICE Data Services and FactSet Research Systems Inc.
Eastman Chemical (EMN) Recycling Gains Raise The Question Of Whether Shares Are A Bargain
Eastman Chemical (EMN) has seen a boost in earnings from its Kingsport methanolysis facility, contributing an additional $60 million in 2025 with $30 million more expected in 2026, alongside a 16-year streak of dividend increases. Despite recent share price fluctuations, the company is considered 16.2% undervalued at $70.71, with a fair value of $84.33, driven by its molecular recycling expansion and potential for sustained revenue growth. Investors are encouraged to assess the balance of rewards and risks, considering factors like global trade tensions and customer adoption rates.
Eastman Chemical (EMN) Recycling Gains Raise The Question Of Whether Shares Are A Bargain
Eastman Chemical (EMN) is gaining attention due to its Kingsport methanolysis facility contributing significant earnings and the company's 16-year streak of dividend increases. Despite recent share price fluctuations, the stock appears undervalued at $70.71 with a fair value estimated at $84.33, driven by its molecular recycling expansion and potential for sustained revenue growth. Investors are encouraged to further evaluate the company's risks and rewards to determine if it presents a genuine investment opportunity.
Eastman Chemical (EMN) Recycling Gains Raise The Question Of Whether Shares Are A Bargain
Eastman Chemical (EMN) is gaining attention for its Kingsport methanolysis facility, which is projected to contribute significantly to earnings in 2025 and 2026, alongside a consistent 16-year streak of dividend increases. Despite recent stock price fluctuations, the company is considered undervalued at $70.71, with a fair value estimated at $84.33, driven by its leadership in molecular recycling and potential for sustained revenue growth and EBITDA margin expansion. Investors are encouraged to assess the risks and rewards to determine if the stock presents a genuine entry point.
Celanese Corp focuses on long term strategy, shares in the specialty chemicals sector spotlight
Celanese Corp is a major specialty chemicals company that balances debt reduction, integration of past deals, and capital returns. The company operates across multiple segments including engineered materials and acetyl derivatives and has a diversified production footprint globally. Investors are focused on how its long-term strategy can sustain cash generation and shareholder returns in a capital-intensive sector.
TriMas (NasdaqGS:TRS) Stock Price
TriMas Corporation (NasdaqGS:TRS) is currently valued with a fair value of US$45.00, placing it at a 0.9% intrinsic discount according to AnalystConsensusTarget. The company, which specializes in consumer products, aerospace, defense, and industrial markets, operates through its Packaging and Specialty Products segments. Recent updates include analyst price target increases and share repurchase activities, with the stock previously noted as undervalued by 20-21% in earlier reports.
Price to earnings forward of Eastman Chemical Company – NYSE:EMN
This article provides the "Price to earnings forward" value for Eastman Chemical Company (NYSE: EMN). The data is supplied by FactSet and ICE Data Services. It is a financial data point for investors interested in the company's valuation.
Price to sales forward of Eastman Chemical Company – NYSE:EMN
This article provides a brief mention of the "Price to sales forward of Eastman Chemical Company" (NYSE: EMN) within the TradingView platform. It highlights that the information pertains to the financial metric for Eastman Chemical Company. The content appears to be a stub or a section of a larger financial data display on TradingView.
Enterprise value to EBITDA forward of Eastman Chemical Company – NYSE:EMN
This article provides financial data for Eastman Chemical Company (NYSE: EMN), specifically focusing on its enterprise value to EBITDA forward metric. The content highlights the company's financial overview on the New York Stock Exchange via TradingView.
1 Core Catalyst Makes Eastman Chemical’s 4.5% Payout a Premier Safe Haven for Retirees Mapping Out the Future
Eastman Chemical (EMN) offers a 4.56% dividend yield, supported by 16 consecutive raises and a 61% adjusted earnings payout ratio. The company's molecular recycling facility in Kingsport is a key growth driver, expected to add significant incremental earnings in 2025 and 2026. While its net debt is elevated for a cyclical company, strong cash flow generation and planned cost reductions provide insulation for its dividend.
Price to sales forward of Eastman Chemical Company – XETR:EAC
This page provides financial data for Eastman Chemical Company (XETR:EAC), specifically focusing on its "Price to sales forward" metric. The content includes an overview of the company's financial information, news, and community discussions available on the TradingView platform. It appears to be a stub or data-focused page with placeholders for actual financial figures.
Price to book forward of Eastman Chemical Company – XETR:EAC
This article provides the "Price to book forward" for Eastman Chemical Company (XETR:EAC). It notes that the market is closed and there are no trades shown. The content is primarily a data placeholder within a financial platform, showing the company's ticker and general market information.
Eastman Chemical Co. stock outperforms competitors on strong trading day
Eastman Chemical Co. (EMN) stock rose 1.32% to $70.40 on Wednesday, outperforming the S&P 500 Index which saw a slight decline. This increase ended a two-day losing streak for the company's shares. The Dow Jones Industrial Average also climbed on a mixed trading day.
Eastman Chemical Co. stock underperforms Tuesday when compared to competitors
Eastman Chemical Co. (EMN) shares dropped 3.45% to $69.48 on Tuesday, underperforming the broader market as the S&P 500 and Dow Jones Industrial Average also saw declines. This marks the second consecutive day of losses for the company's stock.
